BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
-6.77%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$23.1B
AUM Growth
+$23.1B
(-13%)
Cap. Flow
-$142M
Cap. Flow
% of AUM
-0.62%
Top 10 Holdings %
Top 10 Hldgs %
80.48%
Holding
138
New
11
Increased
23
Reduced
15
Closed
12
Top Buys
| 1 |
Immunocore
IMCR
|
$107M |
| 2 |
Instil Bio
TIL
|
$97.7M |
| 3 |
TLIS
Talis Biomedical Corporation Common Stock
TLIS
|
$97.3M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$93.6M |
| 5 |
Design Therapeutics
DSGN
|
$43M |
Top Sells
Sector Composition
| 1 | Healthcare | 97.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
| $6.56B | 28.46% | 47,270,759 +1,335 | +0% | +$185K |
|
|
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $4.06B | 17.61% | 11,668,897 | – | – |
|
3
Incyte
INCY
$16.5B
| $2.6B | 11.28% | 32,001,387 +1,646 | +0% | +$134K |
|
4
Kodiak Sciences
KOD
$478M
| $1.57B | 6.82% | 13,879,952 | – | – |
|
5
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.08B | 4.69% | 41,910,704 +6,118 | +0% | +$158K |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $611M | 2.65% | 3,993,312 -4,767,482 | -54% | -$729M |
|
|
NVTA
7
DELISTED
Invitae Corporation
NVTA
| $602M | 2.61% | 15,749,182 +100,000 | +0.6% | +$3.82M |
|
8
BioMarin Pharmaceuticals
BMRN
$11.2B
| $573M | 2.48% | 7,589,294 | – | – |
|
9
Ascendis Pharma
ASND
$11.8B
| $456M | 1.98% | 3,540,270 | – | – |
|
10
Prelude Therapeutics
PRLD
$68.5M
| $439M | 1.9% | 10,123,824 +5,188 | +0.1% | +$225K |
|
11
AbCellera Biologics
ABCL
$1.25B
| $355M | 1.54% | 10,450,180 | – | – |
|
12
argenx
ARGX
$43.6B
| $308M | 1.34% | 1,119,557 +100,000 | +10% | +$27.5M |
|
|
IGMS
13
DELISTED
IGM Biosciences
IGMS
| $242M | 1.05% | 3,156,102 +11,210 | +0.4% | +$860K |
|
|
MRTX
14
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $241M | 1.05% | 1,409,784 | – | – |
|
15
Madrigal Pharmaceuticals
MDGL
$9.76B
| $175M | 0.76% | 1,499,213 | – | – |
|
|
AMRN
16
Amarin Corp
AMRN
$311M
| $164M | 0.71% | 26,453,422 -1,538,339 | -5% | -$9.55M |
|
|
GBT
17
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $131M | 0.57% | 3,217,441 +2,297,066 | +250% | +$93.6M |
|
18
BioCryst Pharmaceuticals
BCRX
$1.74B
| $129M | 0.56% | 12,710,818 +15,000 | +0.1% | +$153K |
|
|
19
Immunocore
IMCR
$1.62B
| $107M | 0.47% | +2,520,730 | New | +$107M |
|
20
Pacific Biosciences
PACB
$393M
| $107M | 0.46% | 3,201,972 | – | – |
|
|
21
Instil Bio
TIL
$182M
| $97.7M | 0.42% | +3,893,700 | New | +$97.7M |
|
|
TLIS
22
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $97.3M | 0.42% | +7,574,835 | New | +$97.3M |
|
23
Heron Therapeutics
HRTX
$207M
| $97.2M | 0.42% | 5,994,704 | – | – |
|
24
Cerus
CERS
$251M
| $82.4M | 0.36% | 13,713,195 | – | – |
|
|
ALLK
25
DELISTED
Allakos
ALLK
| $80.7M | 0.35% | 703,050 -11,200 | -2% | -$1.29M |
|